Palatin Tech

Q4 FY2026 EarningsFY26 Q4 (ended June 30, 2026) reported revenue of $13.72M, largely in-line with the consensus of $13.72M, driven primarily by licensing revenue from the Boehringer Ingelheim and Altanispac agreements. Normalized EPS of -$2.96 beat the consensus estimate of -$2.99, while GAAP EPS of -$2.96 fell within the expected range, though it significantly improved from -$32.15 YoY due to the reverse stock split and higher revenue. Net Income GAAP of -$8.38M was slightly better than the -$8.71M expected. Despite the top-line beat, management issued a 'going concern' warning as cash reserves of $7.5M are insufficient to fund operations beyond 2026 without further capital raises.